Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00UEC
|
|||
| Former ID |
DNCL003351
|
|||
| Drug Name |
ASP3662
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1 | [1] | |
| Company |
Astellas
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H16ClF3N4O2
|
|||
| Canonical SMILES |
CC(C)(C1=NN=C(N1C)C2=C(C=C(C=C2)C(=O)N)F)OC3=C(C=C(C=C3F)Cl)F
|
|||
| InChI |
1S/C19H16ClF3N4O2/c1-19(2,29-15-13(22)7-10(20)8-14(15)23)18-26-25-17(27(18)3)11-5-4-9(16(24)28)6-12(11)21/h4-8H,1-3H3,(H2,24,28)
|
|||
| InChIKey |
CMQOKZCYVZFZLZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Astellas Pharma. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.